Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Increased attentional network functioning related to symptom severity measures in females with irritable bowel syndrome.

Hubbard CS, Hong J, Jiang Z, Ebrat B, Suyenobu B, Smith S, Heendeniya N, Naliboff BD, Tillisch K, Mayer EA, Labus JS.

Neurogastroenterol Motil. 2015 Sep;27(9):1282-94. doi: 10.1111/nmo.12622. Epub 2015 Jun 19.

2.

Influence of sucrose ingestion on brainstem and hypothalamic intrinsic oscillations in lean and obese women.

Kilpatrick LA, Coveleskie K, Connolly L, Labus JS, Ebrat B, Stains J, Jiang Z, Suyenobu BY, Raybould HE, Tillisch K, Mayer EA.

Gastroenterology. 2014 May;146(5):1212-21. doi: 10.1053/j.gastro.2014.01.023. Epub 2014 Jan 28.

3.

Sex differences in emotion-related cognitive processes in irritable bowel syndrome and healthy control subjects.

Labus JS, Gupta A, Coveleskie K, Tillisch K, Kilpatrick L, Jarcho J, Feier N, Bueller J, Stains J, Smith S, Suyenobu B, Naliboff B, Mayer EA.

Pain. 2013 Oct;154(10):2088-99. doi: 10.1016/j.pain.2013.06.024. Epub 2013 Jun 20.

4.

Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome.

Berman S, Suyenobu B, Naliboff BD, Bueller J, Stains J, Wong H, Mandelkern M, Fitzgerald L, Ohning G, Gupta A, Labus JS, Tillisch K, Mayer EA.

Neuroimage. 2012 Dec;63(4):1854-63. doi: 10.1016/j.neuroimage.2012.08.028. Epub 2012 Aug 21.

5.

Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study.

Tillisch K, Labus J, Nam B, Bueller J, Smith S, Suyenobu B, Siffert J, McKelvy J, Naliboff B, Mayer E.

Aliment Pharmacol Ther. 2012 Feb;35(3):360-7. doi: 10.1111/j.1365-2036.2011.04958.x.

6.

Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain.

Hubbard CS, Labus JS, Bueller J, Stains J, Suyenobu B, Dukes GE, Kelleher DL, Tillisch K, Naliboff BD, Mayer EA.

J Neurosci. 2011 Aug 31;31(35):12491-500. doi: 10.1523/JNEUROSCI.1860-11.2011.

7.

The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome.

Kilpatrick LA, Labus JS, Coveleskie K, Hammer C, Rappold G, Tillisch K, Bueller JA, Suyenobu B, Jarcho JM, McRoberts JA, Niesler B, Mayer EA.

Gastroenterology. 2011 Jun;140(7):1943-51. doi: 10.1053/j.gastro.2011.03.011. Epub 2011 Mar 21.

8.

Impact of Mindfulness-Based Stress Reduction training on intrinsic brain connectivity.

Kilpatrick LA, Suyenobu BY, Smith SR, Bueller JA, Goodman T, Creswell JD, Tillisch K, Mayer EA, Naliboff BD.

Neuroimage. 2011 May 1;56(1):290-8. doi: 10.1016/j.neuroimage.2011.02.034. Epub 2011 Feb 18.

9.

Brain networks underlying perceptual habituation to repeated aversive visceral stimuli in patients with irritable bowel syndrome.

Labus JS, Naliboff BD, Berman SM, Suyenobu B, Vianna EP, Tillisch K, Mayer EA.

Neuroimage. 2009 Sep;47(3):952-60. doi: 10.1016/j.neuroimage.2009.05.078. Epub 2009 Jun 6.

10.

Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study.

Jarcho JM, Chang L, Berman M, Suyenobu B, Naliboff BD, Lieberman MD, Ameen VZ, Mandelkern MA, Mayer EA.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):344-52.

11.

Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis.

Labus JS, Naliboff BN, Fallon J, Berman SM, Suyenobu B, Bueller JA, Mandelkern M, Mayer EA.

Neuroimage. 2008 Jul 1;41(3):1032-43. doi: 10.1016/j.neuroimage.2008.03.009. Epub 2008 Mar 20.

12.

Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study.

Ringel Y, Drossman DA, Leserman JL, Suyenobu BY, Wilber K, Lin W, Whitehead WE, Naliboff BD, Berman S, Mayer EA.

Gastroenterology. 2008 Feb;134(2):396-404. doi: 10.1053/j.gastro.2007.11.011. Epub 2007 Nov 12.

PMID:
18242208
13.

Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome.

Berman SM, Naliboff BD, Suyenobu B, Labus JS, Stains J, Ohning G, Kilpatrick L, Bueller JA, Ruby K, Jarcho J, Mayer EA.

J Neurosci. 2008 Jan 9;28(2):349-59. doi: 10.1523/JNEUROSCI.2500-07.2008.

14.

Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients.

Naliboff BD, Berman S, Suyenobu B, Labus JS, Chang L, Stains J, Mandelkern MA, Mayer EA.

Gastroenterology. 2006 Aug;131(2):352-65.

PMID:
16890589
15.

Sex differences in regional brain response to aversive pelvic visceral stimuli.

Berman SM, Naliboff BD, Suyenobu B, Labus JS, Stains J, Bueller JA, Ruby K, Mayer EA.

Am J Physiol Regul Integr Comp Physiol. 2006 Aug;291(2):R268-76. Epub 2006 Apr 13.

16.

Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis.

Mayer EA, Berman S, Suyenobu B, Labus J, Mandelkern MA, Naliboff BD, Chang L.

Pain. 2005 Jun;115(3):398-409.

PMID:
15911167
17.

The neural correlates of placebo effects: a disruption account.

Lieberman MD, Jarcho JM, Berman S, Naliboff BD, Suyenobu BY, Mandelkern M, Mayer EA.

Neuroimage. 2004 May;22(1):447-55.

PMID:
15110038
18.

Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia.

Chang L, Berman S, Mayer EA, Suyenobu B, Derbyshire S, Naliboff B, Vogt B, FitzGerald L, Mandelkern MA.

Am J Gastroenterol. 2003 Jun;98(6):1354-61.

PMID:
12818281
19.

Sex-related differences in IBS patients: central processing of visceral stimuli.

Naliboff BD, Berman S, Chang L, Derbyshire SW, Suyenobu B, Vogt BA, Mandelkern M, Mayer EA.

Gastroenterology. 2003 Jun;124(7):1738-47.

PMID:
12806606
20.

Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron.

Berman SM, Chang L, Suyenobu B, Derbyshire SW, Stains J, Fitzgerald L, Mandelkern M, Hamm L, Vogt B, Naliboff BD, Mayer EA.

Gastroenterology. 2002 Oct;123(4):969-77.

PMID:
12360456
21.

The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients.

Mayer EA, Berman S, Derbyshire SW, Suyenobu B, Chang L, Fitzgerald L, Mandelkern M, Hamm L, Vogt B, Naliboff BD.

Aliment Pharmacol Ther. 2002 Jul;16(7):1357-66.

22.

Multiband topographic EEG analysis of a simulated visuomotor aviation task.

Sterman MB, Mann CA, Kaiser DA, Suyenobu BY.

Int J Psychophysiol. 1994 Feb;16(1):49-56.

PMID:
8206804

Supplemental Content

Loading ...
Support Center